Toggle Main Menu Toggle Search

Open Access padlockePrints

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic

Lookup NU author(s): Dr Lesley Kay, Dr Bridget Griffiths


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© Royal College of Physicians 2020. All rights reserved.Rheumatology teams care for patients with diverse, systemic autoimmune diseases who are often immunosuppressed and at high risk of infections. The current COVID-19 pandemic has presented particular challenges in caring for and managing this patient group. The office of the chief medical officer (CMO) for England contacted the rheumatology community to provide expert advice on the identification of extremely vulnerable patients at very high risk during the COVID-19 pandemic who should be ‘shielded’. This involves the patients being asked to strictly self-isolate for at least 12 weeks with additional funded support provided for them to remain at home. A group of rheumatologists (the authors) have devised a pragmatic guide to identifying the very highest risk group using a rapidly developed scoring system which went live simultaneous with the Government announcement on shielding and was cascaded to all rheumatologists working in England.

Publication metadata

Author(s): Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A

Publication type: Article

Publication status: Published

Journal: Clinical Medicine

Year: 2020

Volume: 20

Issue: 3

Pages: 256-261

Online publication date: 15/05/2020

Acceptance date: 02/04/2016

ISSN (print): 1470-2118

ISSN (electronic): 1473-4893

Publisher: Royal College of Physicians


DOI: 10.7861/clinmed.2020-0149

PubMed id: 32371418


Altmetrics provided by Altmetric